|4Jul 2, 4:07 PM ET

Lavino Francesco Maria 4

4 · Nabriva Therapeutics plc · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-06-30
Lavino Francesco Maria
Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-06-30$0.67/sh366$247179,000 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4